BioSpace News Archive

Exo (pronounced “echo”), a pioneering health information and devices company, closed a $220 million Series C investment round.

4D pharma plc, a pharmaceutical company leading the development of Live Biotherapeutic products, a novel class of drug derived from the microbiome, announces two poster presentations at the European Society for Medical Oncology Congress, held from September 16-21, 2021.

Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced the first patient implant in a U.S. Food and Drug Administration clinical study that will evaluate the safety and effectiveness of the M6-C™ artificial cervical disc compared to anterior cervical discectomy and fusion for the treatment of contiguous two-level symptomatic cervical radiculopathy.

AVROBIO, Inc., a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, announced that members of its senior management team are scheduled to participate in two upcoming investor conferences:

IMV Inc., a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies against difficult-to-treat cancers, announced that it will hold a conference call and webcast on Wednesday, August 11, 2021 at 8:00 a.m. ET to discuss the company’s second quarter 2021 financial and operational results.

FDA agreed that Galmed can proceed with its proposed clinical studies with Aramchol meglumine in lieu of Aramchol free acid without the need to repeat nonclinical and clinical studies.

Replimune Group, Inc., a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic® platform, announced that members from the Replimune management team will present and host investor meetings at the following two conferences:

Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on oncology and rare diseases, today announced that Dr. Denise Scots-Knight, Chief Executive Officer of Mereo, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference

MiRus™ announced today that Angela Coldwell has joined the company’s Leadership Team as Chief Financial Officer effective July 6, 2021.

The demand form Health is on a rise, owing to surge in incidence of chronic diseases such as diabetes and cancer.